Can the Scope of CRO Services Be Changed During a Grant-Funded Project?
Yes, the scope of services provided by a Contract Research Organization (CRO) can be changed during a grant-funded project. However, such changes require appropriate justification and compliance with the rules established by the funding institution. The procedure for making changes depends primarily on the funding call requirements, the grant agreement, and whether the changes affect the project timeline, budget, or substantive scope.
During a clinical trial, situations may arise that require modifications to the scope of CRO activities. For example, it may be necessary to increase the number of research sites due to slower patient recruitment, expand monitoring activities, obtain additional regulatory support, change the number of monitoring visits, or increase the involvement of the data management team.
Each change should be assessed in terms of its impact on project implementation. If a modification only affects how previously planned activities are carried out and does not affect the budget or project objectives, it can often be implemented under the existing CRO agreement. However, significant changes, such as an increase in service costs, transfers between budget categories, or changes to tasks specified in the grant application, may require approval from the funding institution or an amendment to the agreement.
Particular attention should be paid to publicly funded projects, as the scope of services and costs specified in the funding application form the basis for assessing the eligibility of expenses. Expanding the CRO's scope of work without proper documentation may result in costs being challenged during an audit or create difficulties when settling the grant.
For this reason, it is worth defining the CRO's role, the scope of delegated tasks, and budget assumptions in detail during the project planning stage. It is also good practice to include a change management mechanism in the CRO agreement, setting out the procedure for requesting, assessing, and approving additional work.
If a need arises to change the scope of CRO services, the sponsor should prepare a business and substantive justification, explain how the change will affect trial implementation, and document the decisions made. Transparent change management helps maintain compliance with the funding institution's requirements while ensuring the project proceeds efficiently.
A flexible approach to cooperation with a CRO is particularly important in clinical trials, as their progress may depend on various factors, including recruitment rates, patient availability, regulatory requirements, and the results of ongoing risk assessments. Properly managed changes make it possible to adapt the project to current needs without losing control of the budget or timeline.
